Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy
dc.authorid | Sevinç, Alper/0000-0002-0499-8918 | |
dc.authorwosid | Sevinc, Alper/KFQ-6440-2024 | |
dc.authorwosid | Sevinç, Alper/KPA-4519-2024 | |
dc.contributor.author | Baydar, Mustafa | |
dc.contributor.author | Dikilitas, Mustafa | |
dc.contributor.author | Sevinc, Alper | |
dc.contributor.author | Aydogdu, Ismet | |
dc.date.accessioned | 2024-08-04T20:14:54Z | |
dc.date.available | 2024-08-04T20:14:54Z | |
dc.date.issued | 2005 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Introduction: One of the most common and important side effects of 5-fluorouracil (5-FU) is mucositis with ulcerations in the oral cavity. We investigated the effects of local cryotherapy on mucositis incidence administrated during 5-FU treatment. Methods: In a total of 99 courses, 5-FU and folinic acid combination chemotherapy was given to 40 patients. In our study, we considered every course as a single case, and cryotherapy was given to the some patient in one course but not given in the next. Results: While mucositis developed in 6.7% of the courses given with cryotherapy, this ratio was 38.9% in courses given without cryotherapy, In the logistic regression analysis, development of mucositis had been found to correlate only with cryotherapy. Odds ratio (OR)=11.5; in the 95% confidence interval (CI)=3.2-41.9; (p=0.001). Discussion: Results of initial studies evaluating the effects of cryotherapy in preventing mucositis due to 5-FU based chemotherapy regimens were promising. We concluded that oral cooling prevents 5-FU induced mucositis. This effective prophylactic treatment should be used in patients who are at increased risk for developing 5-FU induced mucositis. | en_US |
dc.identifier.endpage | 1164 | en_US |
dc.identifier.issn | 0027-9684 | |
dc.identifier.issn | 1943-4693 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 16173332 | en_US |
dc.identifier.scopus | 2-s2.0-23244458141 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 1161 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/94039 | |
dc.identifier.volume | 97 | en_US |
dc.identifier.wos | WOS:000203403300012 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Natl Med Assoc | en_US |
dc.relation.ispartof | Journal of The National Medical Association | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | 5-fluorouracil | en_US |
dc.subject | oral mucositis | en_US |
dc.subject | cryotherapy | en_US |
dc.subject | prevention | en_US |
dc.title | Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy | en_US |
dc.type | Article | en_US |